Home
News
Create
Screeners
Insights
Beryl Drugs
20.
20
-0.23
(-1.13%)
Market Cap
₹10.28 Cr
PE Ratio
681.00
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.13%
1M
-8.64%
6M
-16.87%
1Y
-12.21%
5Y
+224.76%
View Company Insights
Latest news about Beryl Drugs
Beryl Drugs Promoter Sudhir Sethi Acquires Additional 3,040 Shares
16 hrs ago
Yesterday
Beryl Drugs Limited disclosed that promoter and director Sudhir Sethi acquired 3,040 shares representing 0.06% of total share capital through market transactions on BSE on 13-03-2026. The transaction, valued at ₹53,504, increased his shareholding from 4,70,143 shares (9.27%) to 4,73,183 shares (9.33%), demonstrating continued promoter confidence in the pharmaceutical company.
Beryl Drugs Limited Reports Q3 FY26 Net Loss of ₹16.77 Lacs Amid Manufacturing Challenges
Feb 09, 2026
Beryl Drugs Limited Files Q3FY26 Compliance Under Regulation 57(5) Stating Non-Applicability
Jan 06, 2026
Beryl Drugs Appoints Directors Under SEBI Regulation 30 Compliance Framework
Jan 05, 2026
Beryl Drugs Reports Q1 Net Profit of Rs 2.11 Lakhs Amid Partial Manufacturing Suspension
Aug 07, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO